Updates matching "Remove Hurdles to Cancer Care"

The American Cancer Society Cancer Action Network (ACS CAN) submitted comments today supporting the U.S. Department of Health and Human Services’ proposed rule to expand federal insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients.

Rhode Island lawmakers have taken the first step towards ensuring cancer patients and others with chronic disease are protected from excessive prescription drug costs.

American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the Arizona Capitol to urge lawmakers to support the reauthorization of the Arizona Health Cancer Cost Containment System (AHCCCS), Arizona’s Medicaid program.

TRENTON, NJ – DECEMBER 19, 2022 – Earlier today, the New Jersey State Senate joined its Assembly counterpart in approving legislation that seeks to remove financial barriers to lifesaving colorectal cancer screening. With the passage of S-2305 by a vote of 37-0, the legislation heads to Governor Murphy’s desk for

As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

ALBANY , NY – DECEMBER 15, 2022 – The costs of being diagnosed with cancer last long after the diagnosis and initial treatment putting cancer survivors at increased risk for lifelong financial hardship, according to a new report from the American Cancer Society Cancer Action Network (ACS CAN).

ALBANY , NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany. WHEN : Santa Clause and

Governor Gavin Newsom vetoed legislation that aimed to enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.

The California Legislature passed a bill that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which was introduced by Senator Monique Limón (D-Santa Barbara) – has received unanimous, bipartisan support throughout the legislative process.